Outcome of relapsed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) after allogeneic hematopoietic cell transplantation (HCT)

被引：0
|
作者：
Heyn, Sinione [1 ]
Krahl, Rainer [1 ]
Lange, Thoralf [1 ]
Eisfeld, Ann-Kathrin [1 ]
Niederwieser, Dietger [1 ]
Al-Ali, Haifa K. [1 ]
机构：
[1] Univ Leipzig, D-7010 Leipzig, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3230.3230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3230
引用
收藏
页码：948A / 948A
页数：1
相关论文
共 50 条
  • [1] Imatinib for relapsed Philadelphia chromosome positive chronic myeloid leukaemia after allogeneic haematopoeitic cell transplantation
    Daneschnejad, S
    Lange, T
    Mueller, C
    Musiol, S
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S234 - S235
  • [2] Secondary Philadelphia chromosome and erythrophagocytosis in a relapsed acute myeloid leukemia after hematopoietic cell transplantation
    Kelemen, Katalin
    Galani, Komal
    Conley, Christopher R.
    Greipp, Patricia T.
    CANCER GENETICS, 2014, 207 (06) : 268 - 271
  • [3] The occurrence of Philadelphia chromosome (Ph) negative leukemia after hematopoietic stem cell transplantation for Ph positive chronic myeloid leukemia: Implications for disease monitoring and treatment
    Au, WY
    Ma, SK
    Kwong, YL
    LEUKEMIA & LYMPHOMA, 2003, 44 (07) : 1121 - 1129
  • [4] Allogeneic Hematopoietic Cell Transplantation (Allogeneic HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael J.
    Cao, Qing
    Trotz, Barb
    Weigel, Brenda
    Kumar, Ashish
    Smith, Angela
    Verneris, Michael R.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (07) : 1289 - 1294
  • [5] Feasibility and toxicity of nommyeloablative hematopoietic cell transplantation (HCT) with or without imatinib for Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL).
    Norasetthada, L
    Maris, MB
    Sandmaier, BM
    Maloney, DG
    Georges, G
    Druker, B
    Radich, J
    Storb, R
    BLOOD, 2004, 104 (11) : 346B - 347B
  • [6] PHILADELPHIA-NEGATIVE (PH-) CHRONIC MYELOID-LEUKEMIA (CML) - COMPARISON WITH PH+ CML AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    MARTIAT, P
    MICHAUX, JL
    RODHAIN, J
    BLOOD, 1991, 78 (01) : 205 - 211
  • [7] IMATINIB MAINTENANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Kebriaei, P.
    Chiattone, A.
    Saliba, R.
    Jones, D.
    Anderlini, P.
    Andersson, B.
    Khouri, I
    Worth, L.
    Ravandi, F.
    Thomas, D.
    Kantarjian, H.
    Hamerschlak, N.
    Rodrigues, M.
    de Lima, M.
    Giralt, S.
    Champlin, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S230 - S230
  • [8] Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation
    Okada, Yosuke
    Tachi, Noriaki
    Shimazu, Yutaka
    Murata, Makoto
    Nishiwaki, Satoshi
    Onishi, Yasushi
    Jinguji, Atsushi
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Hasegawa, Yuta
    Ito, Ayumu
    Kako, Shinichi
    Nishida, Tetsuya
    Onodera, Koichi
    Sawa, Masashi
    Nakamae, Hirohisa
    Toyosaki, Masako
    Kanda, Yoshinobu
    Onizuka, Makoto
    Fukuda, Takahiro
    Ohbiki, Marie
    Atsuta, Yoshiko
    Arai, Yasuyuki
    Tachibana, Takayoshi
    CANCER, 2025, 131 (01)
  • [9] Long-term outcome after allogeneic hematopoietic cell transplantation (HCT) for CML
    Goldman, JM
    Sobocinski, KA
    Zhang, MJ
    Klein, JP
    Ketelsen, SW
    Giralt, SA
    Horowitz, MM
    Rizzo, JD
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 17 - 17
  • [10] Treatment of accelerated phase of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML AP) with imatinib mesylate (STI571).
    Kantarjian, HM
    O'Brien, S
    Cortes, J
    Faderl, S
    Giles, F
    Thomas, D
    Garcia-Manero, G
    Albitar, M
    Rios, MB
    Shan, J
    Issa, JP
    Resta, D
    Capdeville, R
    Keating, MJ
    Freireich, EJ
    Talpaz, M
    BLOOD, 2001, 98 (11) : 141A - 141A
12345